JP2006101735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006101735A5 JP2006101735A5 JP2004290785A JP2004290785A JP2006101735A5 JP 2006101735 A5 JP2006101735 A5 JP 2006101735A5 JP 2004290785 A JP2004290785 A JP 2004290785A JP 2004290785 A JP2004290785 A JP 2004290785A JP 2006101735 A5 JP2006101735 A5 JP 2006101735A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004290785A JP4731867B2 (ja) | 2004-10-01 | 2004-10-01 | Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法 |
| TW093140800A TW200611706A (en) | 2004-10-01 | 2004-12-27 | Cytotoxic t lymphocyte |
| KR1020050001212A KR20060029591A (ko) | 2004-10-01 | 2005-01-06 | 세포 상해성 ｔ 림프구 |
| US11/171,365 US20060073126A1 (en) | 2004-10-01 | 2005-07-01 | Cytotoxic T lymphocyte |
| US12/113,822 US8168191B2 (en) | 2004-10-01 | 2008-05-01 | Cytotoxic T lymphocyte |
| KR1020100008413A KR101008245B1 (ko) | 2004-10-01 | 2010-01-29 | 세포 상해성 ｔ 림프구 |
| US13/431,542 US9243227B2 (en) | 2004-10-01 | 2012-03-27 | Cytotoxic T lymphocyte |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004290785A JP4731867B2 (ja) | 2004-10-01 | 2004-10-01 | Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010191480A Division JP5155368B2 (ja) | 2010-08-27 | 2010-08-27 | 細胞傷害性ｔリンパ球 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006101735A JP2006101735A (ja) | 2006-04-20 |
| JP2006101735A5 true JP2006101735A5 (https=) | 2007-12-20 |
| JP4731867B2 JP4731867B2 (ja) | 2011-07-27 |
Family
ID=36125792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004290785A Expired - Lifetime JP4731867B2 (ja) | 2004-10-01 | 2004-10-01 | Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US20060073126A1 (https=) |
| JP (1) | JP4731867B2 (https=) |
| KR (2) | KR20060029591A (https=) |
| TW (1) | TW200611706A (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101287831B (zh) | 2005-09-13 | 2013-05-15 | 国立大学法人三重大学 | T细胞受体和编码该受体的核酸 |
| EP2072618A1 (en) * | 2007-12-14 | 2009-06-24 | Johannes Gutenberg-Universität Mainz | Use of RNA for reprogramming somatic cells |
| EP3101122B1 (en) * | 2009-08-24 | 2023-06-14 | Baylor College of Medicine | Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
| AU2012302778B2 (en) * | 2011-08-31 | 2016-11-24 | Mie University | Vaccine preparation for cancer treatment |
| GB201121308D0 (en) | 2011-12-12 | 2012-01-25 | Cell Medica Ltd | Process |
| PT2812431T (pt) | 2012-02-09 | 2019-10-18 | Baylor College Medicine | Pepmixes para gerar ctls multivirais com larga especifidade |
| JP6999941B2 (ja) | 2015-09-18 | 2022-02-10 | ベイラー カレッジ オブ メディスン | 病原体からの免疫原性抗原同定および臨床的有効性との相関 |
| GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
| GB201520543D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
| KR102770425B1 (ko) | 2016-02-08 | 2025-02-18 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 면역체크포인트 저해제 저항성 종양에 대한 t세포 수주요법의 전처치약 |
| US10821134B2 (en) | 2017-05-17 | 2020-11-03 | Board Of Regents, The University Of Texas System | BK virus specific T cells |
| TWI793151B (zh) | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| DK3820573T3 (da) | 2018-07-10 | 2023-10-23 | Novartis Ag | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme |
| AR116109A1 (es) | 2018-07-10 | 2021-03-31 | Novartis Ag | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos |
| US10772914B1 (en) | 2019-04-18 | 2020-09-15 | Baylor College Of Medicine | EBV-specific immune cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7001999B1 (en) * | 1998-04-15 | 2006-02-21 | Ludwig Institute For Cancer Research | Tumor associated nucleic acids and uses therefor |
| EP1911461B1 (en) | 2000-10-19 | 2011-12-07 | Epimmune Inc. | HLA class I and II binding peptides and their uses |
| US7311914B2 (en) * | 2002-08-13 | 2007-12-25 | Ludwig Institute For Cancer Research | MAGE-A4 antigenic peptides and uses thereof |
| US20050249743A1 (en) * | 2004-01-12 | 2005-11-10 | Thierry Boon-Falleur | Isolated peptides which bind to HLA-A24 molecules and uses thereof |
-
2004
- 2004-10-01 JP JP2004290785A patent/JP4731867B2/ja not_active Expired - Lifetime
- 2004-12-27 TW TW093140800A patent/TW200611706A/zh not_active IP Right Cessation
-
2005
- 2005-01-06 KR KR1020050001212A patent/KR20060029591A/ko not_active Ceased
- 2005-07-01 US US11/171,365 patent/US20060073126A1/en not_active Abandoned
-
2008
- 2008-05-01 US US12/113,822 patent/US8168191B2/en not_active Expired - Fee Related
-
2010
- 2010-01-29 KR KR1020100008413A patent/KR101008245B1/ko not_active Expired - Fee Related
-
2012
- 2012-03-27 US US13/431,542 patent/US9243227B2/en not_active Expired - Fee Related